ISSN (Print) - 0012-9976 | ISSN (Online) - 2349-8846
-A A +A

SRI LANKA-The Quagmire

Unichem which produces one of the leading brands, EP Forte injections and tablets, has in the last three months produced 37 batches each of two lakh tablets which is 24,00,000 packs. In addition it has produced 26,50,000 ampoules of the EP Forte injections. What would happen now if the DCI bans the drug? As has been the case before, the industry will no doubt argue that it be allowed to sell existing stock. In other words, the DCI will be persuaded by the industry be allowed to continue marketing a drug which its own expert committees, including the one constituted by the ICMR, have pronounced to be harmful. Unichem has also been distributing product literature about its EP products which categorically denies that the drug is harmful. No mention is made about the fact that its safety, or for that matter its relevance, is under discussion among experts.

Subscribers please login to access full text of the article.

New 3 Month Subscription
to Digital Archives at

826for India

$50for overseas users

Get instant access to the complete EPW archives

Subscribe now

Comments

(-) Hide

EPW looks forward to your comments. Please note that comments are moderated as per our comments policy. They may take some time to appear. A comment, if suitable, may be selected for publication in the Letters pages of EPW.

Back to Top